Literature DB >> 27885853

Nomogram for radiation-induced hypothyroidism prediction in nasopharyngeal carcinoma after treatment.

Ren Luo1, Mei Li1, Zhining Yang1, Yizhou Zhan1, Baotian Huang1, Jiayang Lu1, Zhenxi Xu1, Zhixiong Lin1.   

Abstract

OBJECTIVE: The aim of this study was to develop a nomogram for radiation-induced hypothyroidism (RHT) prediction.
METHODS: We collected data from 164 patients with nasopharyngeal carcinoma (NPC) in our previous prospective study. Biochemical hypothyroidism was defined as a serum thyroid-stimulating hormone level greater than the normal value. We collected both clinical and dose-volume factors. A univariate Cox regression analysis was performed to identify RHT risk factors. Optimal predictors were selected according to the least absolute shrinkage and selection operator (LASSO). We then selected the Cox regression models that best balanced the prediction performance and practicability to build a nomogram for RHT prediction.
RESULTS: There were 38 (23.2%) patients who developed RHT, and the median follow-up was 24 months. The univariate Cox regression analysis indicated that gender, minimum dose, mean dose (Dmean) and V25-V60 [Vx (%), the percentage of thyroid volume receiving >x Gy] of the thyroid were significantly associated with RHT. The variables of gender, receiving chemotherapy or not (chemo), Dmean and V50 were selected using the LASSO analysis. A nomogram based on a three-variable (gender, chemo and V50) Cox regression model was constructed, and its concordance index was 0.72. Good accordance between prediction and observation was showed by calibration curves in the probability of RHT at 18, 24 and 30 months.
CONCLUSION: This study built a nomogram for RHT in NPC survivors by analyzing both clinical and dose-volume parameters using LASSO. Thus, the individual dose constraint could be achieved in a visual format. Advances in knowledge: This study used LASSO to more accurately address the multicollinear problem between variables. The resulting nomogram will help physicians predict RHT.

Entities:  

Mesh:

Year:  2016        PMID: 27885853      PMCID: PMC5685104          DOI: 10.1259/bjr.20160686

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  42 in total

Review 1.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

2.  Hypothyroidism when the thyroid is included only in the low neck field during head and neck radiotherapy.

Authors:  Anna A Norris; Robert J Amdur; Christopher G Morris; William M Mendenhall
Journal:  Am J Clin Oncol       Date:  2006-10       Impact factor: 2.339

3.  Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck.

Authors:  A D Colevas; R Read; J Thornhill; S Adak; R Tishler; P Busse; Y Li; M Posner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-11-01       Impact factor: 7.038

4.  Normal tissue complication probability (NTCP) models for late rectal bleeding, stool frequency and fecal incontinence after radiotherapy in prostate cancer patients.

Authors:  Wouter Schaake; Arjen van der Schaaf; Lisanne V van Dijk; Alfons H H Bongaerts; Alfons C M van den Bergh; Johannes A Langendijk
Journal:  Radiother Oncol       Date:  2016-05-03       Impact factor: 6.280

5.  A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model.

Authors:  Marjolein J Boomsma; Hendrik P Bijl; Miranda E M C Christianen; Ivo Beetz; Olga Chouvalova; Roel J H M Steenbakkers; Bernard F A M van der Laan; Bruce H R Wolffenbuttel; Sjoukje F Oosting; Cornelis Schilstra; Johannes A Langendijk
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-19       Impact factor: 7.038

6.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

7.  Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer: a retrospective analysis of seventy-three patients.

Authors:  Daniela Alterio; Barbara Alicja Jereczek-Fossa; Benedetta Franchi; Alberto D'Onofrio; Valeria Piazzi; Elena Rondi; Mario Ciocca; Bianca Gibelli; Enrica Grosso; Nicoletta Tradati; Luigi Mariani; Genoveva Ionela Boboc; Roberto Orecchia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-02       Impact factor: 7.038

8.  Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.

Authors:  Roberto Diaz; Jerry J Jaboin; Manuel Morales-Paliza; Elizabeth Koehler; John G Phillips; Scott Stinson; Jill Gilbert; Christine H Chung; Barbara A Murphy; Wendell G Yarbrough; Patrick B Murphy; Yu Shyr; Anthony J Cmelak
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-04       Impact factor: 7.038

9.  Thyroid dysfunction after radiotherapy in children with Hodgkin's disease.

Authors:  L S Constine; S S Donaldson; I R McDougall; R S Cox; M P Link; H S Kaplan
Journal:  Cancer       Date:  1984-02-15       Impact factor: 6.860

10.  Primary and central hypothyroidism after radiotherapy for head-and-neck tumors.

Authors:  Niranjan Bhandare; Laurence Kennedy; Robert S Malyapa; Christopher G Morris; William M Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-04-18       Impact factor: 7.038

View more
  9 in total

Review 1.  Revisiting the dose constraints for head and neck OARs in the current era of IMRT.

Authors:  N Patrik Brodin; Wolfgang A Tomé
Journal:  Oral Oncol       Date:  2018-09-08       Impact factor: 5.337

Review 2.  An update in musculoskeletal tumors: from quantitative imaging to radiomics.

Authors:  Vito Chianca; Domenico Albano; Carmelo Messina; Gabriele Vincenzo; Stefania Rizzo; Filippo Del Grande; Luca Maria Sconfienza
Journal:  Radiol Med       Date:  2021-05-19       Impact factor: 3.469

3.  Application of Multi-Scale Fusion Attention U-Net to Segment the Thyroid Gland on Localized Computed Tomography Images for Radiotherapy.

Authors:  Xiaobo Wen; Biao Zhao; Meifang Yuan; Jinzhi Li; Mengzhen Sun; Lishuang Ma; Chaoxi Sun; Yi Yang
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

4.  A New Model for Predicting Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma.

Authors:  Liang Peng; Yan-Ping Mao; Cheng-Long Huang; Rui Guo; Jun Ma; Wei-Ping Wen; Ling-Long Tang
Journal:  Front Oncol       Date:  2020-09-25       Impact factor: 6.244

5.  Dose-volume derived nomogram as a reliable predictor of radiotherapy-induced hypothyroidism in head and neck cancer patients.

Authors:  Marin Prpic; Ivan Kruljac; Davor Kust; Petar Suton; Neva Purgar; Lora Kirigin Bilos; Marin Gregov; Iva Mrcela; Maja Franceschi; Nikola Djakovic; Ana Frobe
Journal:  Radiol Oncol       Date:  2019-11-20       Impact factor: 2.991

Review 6.  Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review.

Authors:  James C H Chow; Ka-Man Cheung; Gavin T C Cheung; Anthony H P Tam; Jeffrey C F Lui; Francis K H Lee; Kwok-Hung Au; Wai-Tong Ng; Anne W M Lee; Harry H Y Yiu
Journal:  Clin Transl Radiat Oncol       Date:  2022-01-24

7.  Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.

Authors:  Ren Luo; Vincent W C Wu; Binghui He; Xiaoying Gao; Zhenxi Xu; Dandan Wang; Zhining Yang; Mei Li; Zhixiong Lin
Journal:  BMC Cancer       Date:  2018-05-18       Impact factor: 4.430

8.  Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial.

Authors:  Chawalit Lertbutsayanukul; Sarin Kitpanit; Anussara Prayongrat; Danita Kannarunimit; Buntipa Netsawang; Chakkapong Chakkabat
Journal:  J Radiat Res       Date:  2018-07-01       Impact factor: 2.724

9.  Thyroid V50 is a risk factor for hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: a retrospective study.

Authors:  Ling Zhou; Jia Chen; Wei Shen; Zheng-Lu Chen; Shuang Huang; Chang-Juan Tao; Ming Chen; Zhong-Hua Yu; Yuan-Yuan Chen
Journal:  Radiat Oncol       Date:  2020-03-23       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.